Trump Announces Deals to Lower Costs and Expand Coverage for Obesity Drugs
President Trump announced a deal with Eli Lilly and Novo Nordisk to expand coverage and lower prices for obesity drugs Wegovy and Zepbound, including Medicare coverage starting next year and phased price reductions for uninsured patients, aiming to improve access and affordability of these effective treatments.
